Alexza Reports Fourth Quarter and Year End 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Alexza Pharma (ALXA) Reports Q4 Loss of $0.15/Share; Warns it May Shut Down
March 28, 2016 4:12 PM EDTAlexza Pharma (NASDAQ: ALXA) reported Q4 EPS of ($0.15), versus ($0.35) reported last year. Revenue for the quarter came in at $673 thousand, versus $1.45 million reported last year.
Alexza believes that, based on its cash and cash equivalent balances at December 31, 2015, the additional $1.0 million drawn... More
